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For a long time the thymus was considered to be an intrinsic primary steps towards tolerance occur within the thymus. To
complete their differentiative programme, immature T cellscomponent of the endocrine system but the endocrine model
of cell-to-cell signalling failed to be fully validated in this receive signals from the thymic cellular microenvironment.
Such signals may be emitted by thymic stromal cells ( likeorgan. With the discovery of its primary role in
T-lymphopoiesis, the endocrine role of the thymus progress- hormones or cytoldnes), or may result from direct interactions
between cell adhesion molecules expressed on pre-T cellsively vanished from the literature, although the thymic influ-
ence was still believed to be mediated by a humoral (thymocytes) and thymic stromal cells (4, 5). During differ-
entiation, immature T cells randomly rearrange the genesmechanism (1). However, in the past 15 years, the question
of a neuroendocrine component in thymic physiology has coding for the segments of their TCR. Many of these random
TCR combinations are orientated against self-antigens whichresurfaced. From a number of studies, it now appears that
the thymus is a crucial site for cross-talk between the neuro- are expressed in the thymic microenvironment, then presented
by proteins encoded in the major histocompatibility complexendocrine and immune systems, especially during foetal devel-
opment (2). Thymic epithelial cells (TEC) and nurse cells (MHC). The interaction of self-reactive T cell clones with
their cognate self-antigens is thought to lead to their negative(TNC) express a repertoire of neuroendocrine-related genes/
precursors, and thymic polypeptides may serve as signals selection, either by programmed cell death (apoptosis), or by
developmental arrest. This process of thymic clonal deletioninteracting with receptors on developing pre-T lymphocytes.
This cryptocrine form of cell-to-cell signalling could play a was demonstrated with the use of mouse mammary tumour
virus (MMTV )-encoded superantigens (6), and with trans-role in T cell development and maturation. In addition, there
is ample evidence that thymic neuroendocrine-related poly- genic mice expressing a TCR specific for the male antigen
(H-Y ) (7). Since the thymus does not express all the compon-peptides behave as self-antigens which are presented to pre-
T cells, and could induce the negative selection of T cells ents of the self-structure, this organ does not delete all
potential autoreactive T cells. Consequently, the existence ofbearing a randomly rearranged antigen receptor (TCR) ori-
entated against endogenous neuroendocrine families (self- other mechanisms for developing tolerance (such as T cell
anergy) at the periphery was postulated, and they werereactive T cells). The objective of this review is to expose
most of the scientific arguments which support the important effectively shown to intervene in the process of immunological
self-tolerance. Nevertheless, thymic clonal deletion of self-role of the thymus in the education of T lymphocytes to
recognize and tolerate neuroendocrine functions. reactive T cells is by far the most important mechanism
involved in self-education of the immune system (8).
The establishment of immunological self-tolerance
The paradox of thymus selection (T cell life) and self-tolerance
Two fundamental properties characterize the immune system: induction (T cell death)
the presence of cellular and molecular elements which defend
the host against a universe of infectious agents (non-self ) Self-peptides are not only involved in the induction of central
T cell self-tolerance but also intervene in the process of T celland, simultaneously, its inability to react against its host.
This latter property is called immunological self-tolerance. maturation and positive selection (9, 10). Thus, the thymus is
the site for an important paradox of contemporary cell biology:The induction of self-tolerance involves a cascade of mechan-
isms, from the early steps in immune cell ontogeny to an How can T lymphocytes be both positively and negatively
selected in the thymic microenvironment (11)? A first explana-advanced stage in life (3). For the T lymphocyte system, the
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tion proposed that TEC were responsible for T cell positive deficiencies. The DiGeorge syndrome is characterized by the
congenital absence of thymus, parathyroids, as well as defectsselection, whereas other thymic bone-marrow derived stromal
cells (macrophages and dendritic/interdigitating cells) induced in the heart and truncal vessels. It has been suggested that this
syndrome results from the failure of the migration of thedeletion of self-reactive T cell clones (12, 13). However, this
hypothesis is not supported by recent experiments which have cephalic neural crest (22, 23). Mice in which the homeobox
gene hox-1.5 was disrupted present thymic aplasia, parathyroidestablished that TEC also are able to delete self-reactive T cells
(14). The ‘avidity/affinity hypothesis’ has been proposed as hypoplasia or aplasia, reduced thyroid tissue, and frequently
associated defects in the heart and great arteries (24).another explanation of the thymic paradox (15, 16). This
hypothesis is based on experiments showing that lymphocytes A particular population of TEC in the outer and subcapsu-
lar cortex are TNC (25). They are very large epithelial cellsbearing transgenic TCRs (specific for defined antigens) do not
mature in organ cultures of foetal thymuses from MHC class (with a diameter up to 50 mm) which contain a number of
internalized thymocytes (immature or pre-T lymphocytes).I-defective animals. However, they do so if peptides related to
the cognate antigen of their TCR are added in the cultures. So, The thymocytes in TNC are not phagocytosed, but are
engulfed within caveoles delimited by TNC plasma mem-T lymphocytes are positively selected if their TCR is barely
engaged with self-peptide at low concentrations (10−12 M), and brane; this process is called ‘emperipolesis’. Within TNC
caveoles, thymocytes display a high mitotic index (26).are deleted if TCR is strongly engaged with self-peptide at high
concentrations (10−6 M). Since the affinity of a TCR for its Functionally, TNC may be involved in T-cell negative selec-
tion since TNC-derived cell line has been shown to inducecognate antigen is rather low (10−8 M at the maximum) (17),
the intrathymic concentration of self-peptides is of crucial impor- in-vitro deletion of thymocytes bearing transgenic TCR (27).
Ultrastructural analyses have confirmed that TNC are nottance for determining positive or negative T cell selection. If the
experiments mentioned above have convincingly shown that only able to present antigens, but also possess the intracellular
machinery for antigen processing (28).T cell selection is peptide-specific, and depends on ligand concen-
tration, one may question the nature and the amount of The thymic stroma also includes cells derived from bone
marrow: macrophages and dendritic cells. Macrophages arepeptide/MHC combinations that contribute in vivo to positive
or negative selection of a particular TCR in a normal thymus. dispersed troughout thymic parenchyme, in the cortex, as
well as in the medulla. Dendritic/interdigitating cells representBecause of their high polymorphism, thymic MHC proteins
cannot establish the discrimination between self and nonself the main population that strongly expresses MHC class II
proteins in the thymic medulla (29).antigens. Given the hazardous nature of the recombination of
TCR gene segments, an important question now is the precise The expression of MHC class I and II molecules by thymic
macrophages and dendritic cells is linked to their activity asidentity of thymic peptides which are presented to developing
T cells and which support T cell positive and negative selection professional antigen-presenting cells (APC ).
The thymus has been long considered as a lymphoepithelial(18).
organ (30) and the lymphoid compartment forms a ‘passenger’
cell population of the thymus. Firstly from foetal liver thenDevelopment of the thymic cellular microenvironment
from bone marrow (31), T cell precursors are attracted and
migrate within the thymus where they engage in different typesThe term ‘thymus’ is derived from the Greek word ‘Hymos’,
and means both ‘courage’ and ‘thyme’. Galien suspected that of interactions with TEC and thymic stromal cells. Different
forms of cell-to-cell signalling can be distinguished along thethe thymus could be the seat of courage and affection because
of its vicinity close to the heart (19). The general shape of pathways of T cell differentiation, namely cell-to-cell adhesion
and autocrine/paracrine signalling. However, with the exceptionthe thymus resembles the leaves of the thyme plant. The
major part of the thymic parenchyme is constituted by an of rare paraneoplastic syndromes leading to the oversecretion
of thymic hormones into the bloodstream, the classic (neuro)-epithelium which expands from the endoderm of the third
pharyngeal pouch on each side into the surrounding mesen- endocrine type of cell-to-cell signalling is not encountered within
the thymus. From 100 T cell precursors which migrate into thechyme. During the expansion of the endoderm, some ecto-
derm is incorporated into the epithelial primordium (20, 21). thymic environment, about only 10 mature T lymphocytes will
leave the lymphoid organ in a state of functional competenceInclusion of ectodermal cells could explain the heterogeneity
of TEC, but also the analogous immunophenotype of TEC and self-tolerance. Thus, the thymus is primarily a ‘graveyard’
for self-reactive T lymphocytes.from the medulla and the outer cortex of thymic lobules. The
interactions of the epithelial rudiment with mesenchymal cells
from the cephalic neural crest are absolutely necessary for a Thymic neurohypophysial-related peptides
proper development of the thymus (22). Only after inter-
actions have occurred between endodermal epithelium and At the beginning of this century, Ott and Scott described the
galactogogue activity of thymic extracts injected into the goatmesenchymal cells derived from the neural crest is the primor-
dial thymus competent to attract lymphoid stem cells and (32). At that time, oxytocin (OT) had not been identified as
the primary mediator of galactokinesis and the oxytocicprovide the epithelial microenvironment within which pre-
T cells may proliferate and differentiate. This was shown by activity of thymic extracts was not further characterized.
Ir-OT could be extracted by acetic acid from human thymusesthe important thymic developmental defects which follow
ablation of the cephalic neural crest (22). Both in human and quantified by a specific RIA using antiserurn AS02
against OT (33). High performance liquid chromotographyconditions and in animal models, there are examples in which
the defective thymic development is accompanied by immune (HPLC) analysis showed a single peak of ir-OT eluting with
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the same retention time as synthetic OT. On isolated rat pressed by TEC and TNC, we hypothesized a processing of
thymic proOT that could be related to antigen presentationuterus, thymic extracts induced oxytocic contraction and the
instead of classical neurosecretion.bioactivity quantitatively concorded with the amounts
Using affinity-chromatography with a monoclonal anti-detected by RIA. The galactogogue action of human foetal
body (mAb) directed against the monomorphic part of humanthymic extracts was also described (34). Ir-neurophysin, the
MHC class I molecules (50), we identified in TEC/TNC10 kDa protein associated in the structure of all neurohypo-
plasma membranes a 55-kDa protein which was labelledphysial precursors, was also detected in the human thymus
both by anti-MHC class I mAb and anti-neurophysin anti-and analysed by G-75 gel filtration. The molar ratio of irOT
bodies (51). Since anti-neurophysin antiserum does not(2.2–18.4 ng/g) to ir-neurophysins (24–142 ng/g) was similar
crossreact neither with MHC class I proteins, nor withto that found in the hypothalamo-neurohypophysial axis,
b2-microglobulin, this 55-kDa membrane protein may repres-suggesting a local synthesis from a common precursor.
ent a hybrid protein including both a neurophysin domainPositive dot blot hybridizations of human thymic mRNA
(10 kDa) and a MHC class I heavy chain-related domainwith bovine OT and vasopressin (VP) cDNA probes provided
(45 kDa). The precise biochemical mechanisms under thisanother argument for in-situ synthesis (35). Independently,
hybrid neurohypophysial/MHC class I membrane proteinir-VP was also detected in rat thymic extracts and thymic VP
remain to be deciphered. The origin of this protein couldconcentrations were shown to be regulated by steroids (36).
reside at the post-transcriptional level (such as a trans-splicingThe presence of ir-OT was confirmed by HPLC in the rat
phenomenom) or at the post-translational level (such as thethymus and rat thymic ir-OT concentrations were modulated
ATP-dependent binding of ubiquitin to protein targeted toby different treatments, further supporting the intrathymic
proteolysis). Following this putative explanation, the MHCsynthesis of an OT-like peptide (37). Contrary to the case in
class I domain would be implicated in membrane targetinghumans, the content of ir-OT in the rat thymus increases
of this hybrid protein, whereas neurophysin binds OT forwith ageing (from 80.4±5.2 to 249.2±13.5 pg/mg protein),
presentation to pre-T cells. Other authors have shown thewhile ir-VP concentration decreases (from 8.2±0.7 to
translocation of a neurophysin-like material in the cell mem-1.75±0.2 pg/mg protein) (38). Ir-VP was also detected in the
branes of cancer cells, and have provided strong argumentshuman thymus but VP concentrations (0.01–0.06 ng/g) were
supporting the behaviour of neurohypophysial-related pep-much lower. Thus, at the peptide level, both in the human
tides as candidate tumoral antigens (52, 53). Thus, both inand in the rat thymus, OT is the dominant peptide of the
the hypothalamo-neurohypophysial axis and in the thymus,neurohypophysial family. Nevertheless, using a 3∞ RACE-
the neurophysin part of the OT precursor fulfils the samePCR, both proOT and proVP genes were shown to be
function: binding of the active non-apeptide OT and tranporttranscribed in the murine thymus (39). The hypothesis that
to the external limit of neurones or TEC/TNC. The tyrosinethe thymus could be the site of expression of another neurohy- residue in position 2 of OT and VP plays an important role
pophysial-related gene (such as vasotocin) was also examined in their binding to neurophysin (54). Interestingly, the tyro-
(40), but there is no evidence that the mammalian genome sine residue in the same position plays a crucial role in
contains additional neurophysin-related genes (41). the binding of antigens to some MHC class 1 alleles for
By immunocytochemistry, TEC and TNC from different their presentation (55). The particular features of thymic
species were shown to express polypeptide precursors of the OT-mediated T cell education to the neurohypophysial family
neurohypophysial family, and the use of specific mAbs against can be related to the observation of a dissociation between
OT and VP revealed a dominance of the OT lineage (42, 43). thymic T cell education to self and peripheral T cell recogni-
In a transgenic rat model, an overexpression of VP was also tion of antigens (56). Moreover, in addition to the presenta-
detected in the epithelial compartment of the thymus (44). tion by MHC class I and II proteins, recent studies have
Thymic nurse cells constitute an intimate neuroendocrine- revealed the existence of other mechanisms of antigen pre-
immune microenvironment since their epithelial component sentation by nonpolymorphic molecules (such as CD1 (57)).
(but not the TNC-engulfed pre-T cells) contains neurohypo- The antigenic behaviour of thymic OT was further demon-
physial-related peptides and expresses the phenotype of strated by another type of experiments. The immunological
neuroendocrine cell types (45). However, the synthesis of OT recognition of OT by specific mAbs at the outer surface of
in TEC/TNC is not coupled with the secretion of the non- human TEC plasma membrane induced a marked secretion
apeptide or its neurophysin in the supernatant of human of the cytokines interleukin-6 (IL-6) and leukaemia inhibitory
TEC/TNC primary cultures. In the murine thymus, ir-OT is factor (LIF) in the supernatant of TEC cultures (58). Given
not located in secretory granules but is diffuse in the cytosol, the nature of the epitopes recognized by anti-OT mAbs, we
in vesicles of the endoplasmic reticulum, and associated with were able to conclude that the molecule OT is fully processed
keratin filaments (46). Interestingly, similar ultrastructural at the level of the TEC plasma membrane. The absence of
features were also reported for OT and VP expressed by biological effects following the treatment of TEC cultures
murine spleen eosinophil-like cells (47). with anti-VP mAbs supports the hypothesis that thymic
As discussed above, the thymic function is closely associ- OT behaves as the self-antigen of the neurohypophysial
ated with the presentation of the self-molecular structure to hormone family.
developing T cells. This action was long thought to be
mediated by thymic macrophages and dendritic cells only,
Cryptocrine signalling in the thymus network
but there is now considerable evidence that TEC and TNC
are actively involved in the induction of central self-tolerance The model of cell-to-cell cryptocrine signalling has been
proposed by Funder (59) to characterize the direct(48, 49). Since OT and its associated neurophysin are coex-
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membrane-to-membrane exchange of chemical informations to make functional this intra-thymic signalling. This is not
the case for the neurohormones OT and VP, due to their lowbetween large epithelial nursing cells ( like Sertoli cells in the
testis or TNC in the thymus) and immature elements which blood concentration. The precise phenotype of the pre-T cell
subsets which are expressing neurohypophysial receptorsmigrate and differentiate at their contact (respectively, sperm-
atids or thymocytes). Besides its role as a self-antigen, there inside the thymus remains to be further defined.
The existence of a functional signalling between thymicis evidence that OT mediates a cryptocrine-type signalling
between TEC and TNC and pre-T cells. Neurohypophysial OT and receptors expressed by immature and cytotoxic T cells
raises the possibility of modulating T cell activity by OTpeptide binding sites have been detected in the rat thymus
and on rat thymocytes (60, 61), on a murine pre-T cell line receptor antagonists. In whole-blood cell cultures, OT hexa-
peptide antagonists inhibit the production of interleukin-1b(RL12-NP) (62) and on murine cytotoxic T cells (62, 63).
The Kd of neurohypophysial peptide binding sites expressed (IL-1b) and IL-6 elicited by human T cell activation with
anti-CD3 mAb (70). Specific antagonists of OT receptorsby murine T cells was 0.15±0.07 nM. In the rat thymus,
oestrogens were shown to increase the affinity of OT expressed by immune cells could offer a therapeutic benefit
in circumstances during which a relapse of severe devastatingbinding sites from 0.199±0.016 to 0.122±0.008 nM (64).
Interestingly, using specific molecular cDNA probes, the autoimmune diseases must be avoided (such as during post
partum or during lactation).expression of the rat V 1b (or V3) receptor was identified in
tissues outside the anterior pituitary, including the thymus
(65). Very recently, using RT-PCR and specific probes, the Application to other neuroendocrine polypeptide families
expression of OT receptor was identified on mouse CD3−
and CD3+ thymocytes (66). The mitogenic effect of neurohy- A number of neuroendocrine-related polypeptides have been
detected and characterized in TEC and thymic stromal cellspophysial peptides on rat thymocytes was first described in
1969 (67), while OT was reported to stimulate glucose from different species (Table 1). Neurotensin (NT) and
somatostatin have been extracted from the chicken thymus,oxidation by rat thymocytes (68). On the basis of antagonist
effects, murine pre-T cells seem to express a Vlb (or V3) especially after hatching, and have been characterized both
immunochemically and chromatographically (71). Recently,subtype of VP receptor, while mature cytotoxic T cells har-
bour receptors of the OT-type. This suggests that the neuro- we have shown that ir-NT is expressed at the cell surface of
human TEC. Cultured human TEC contain ±5 ng ir-NT/106hypophysial receptors expressed by T lymphocytes could
‘mature’ in parallel with their differentiation. In both T cell cells, of which 5% is associated with plasma cell membranes.
High performance liquid chromatography analysis of ir-NTtypes, neurohypophysial peptide receptors transduce low con-
centrations of both OT and VP (1 nM) via the phosphoinosi- present in human TEC revealed a major peak of ir-NT
corresponding to intact NT1–13. Ir-NT was not detected intide pathway. Neurohypophysial-related signals (1 nM)
increase the incorporation of tritiated thymidine by freshly the supernatant of human TEC primary cultures. Using an
affinity column prepared with an anti-MHC class I Ab,isolated murine thymocytes, suggesting a mitogenic effet (62).
The observations of numerous points of focal adhesion NT-related peptides were retained on the column and were
eluted together with MHC class I proteins (72).between OT-containing TEC and immature T cells (46) led
us to investigate the hypothesis that neurohypophysial Neurokinin A (NKA) is the peptide of the tachykinin
family encoded in human and rat TEC by the preprotachyki-peptides could stimulate focal adhesion-related kinases in
thymocytes. Western blots of RL12-NP-extracted proteins nin A (PPT-A) gene (73). Thymic PPT-A expression appearsto be glucocorticoid-dependent since adrenalectomy ofwith anti-phosphotyrosine revealed a number of proteins, the
phosphorylation of which was stimulated either by OT or Sprague-Dawley rats markedly enhances thymic expression
of PPT-A (and NPY ) mRNAs (Ericsson and Geenen, unpub-VP (both at 1 nM). Two of these proteins were precipitated
with anti-focal adhesion (FAK) mAb 2A7; one was identified lished observations). Interestingly, NKA exerts IL-1-like
mitogenic effects on murine thymocytes (74), suggesting thatas p125FAK and the other as a coprecipitating 130-kDa protein
(probably p130Cas). Another protein phosphorylated by OT tachykinin receptors expressed by immature T cells could be
implicated in an accessory pathway for T cell maturation andin RL12-NP cells was identified as paxillin, a 68-kDa protein
located at focal adhesion sites and associated with p125FAK. positive selection. The amino acid sequence of NKA shares
the same C-terminal epitope with other members of theOxytocin was more potent than VP in inducing p125FAKphosphorylation and this OT effect was inhibited by a V1 tachykinin family, and the leucine residue in position 9 could
be used in the binding to some MHC class I alleles, thusreceptor antagonist, confirming that immature T cells bear
V1-type VP receptors (69). Stimulation of focal adhesions making NKA the self-antigen of the tachykinin family. The
other tachykinin encoded by PPT-A, substance P, is notcould promote T cell interactions with the thymic cellular
microenvironment which are fundamental for the T cell detected in TEC but is present in sensory nerve fibres of the
thymus (75). Thymic specific receptors for substance P aredifferentiation programme. Thus, the bulk of available data
support the existence of a cryptocrine cell-to-cell signalling associated with the vasculature in the medulla, where they
could control local blood flow and vascular permeability (76).within the thymus that is mediated by neurohypophysial-
related signals originating in TEC and TNC and their func- The expression in the rat thymus of natriuretic peptides
(ANP, BNP and CNP) is well documented. ANP seems totional receptors expressed by developing T cells. Because the
intrathymic ir-OT concentrations are in agreement with the be the dominant thymic peptide and is expressed by thymic
macrophages, while ir-CNP is expressed by thymocytes. Thehigh affinity Kd of neurohypophysial receptors expressed by
pre-T cells, general physico-chemical considerations are met different types of natriuretic peptide receptors were also
© 1998 Blackwell Science Ltd, Journal of Neuroendocrinology, 10, 811–822
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T 1. The Repertoire of Neuroendocrine Peptides Expressed in the Thymus.
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detected by RT-PCR (77, 78). Treatment of murine foetal In the line of our working model that central T cell tolerance
of neuroendocrine functions is induced by the thymic reper-thymic organ cultures (FTOC) with ANP has been shown
to decrease the total thymocyte yield in FTOC and to increase toire of neuroendocrine self-antigens, a series of investigations
were undertaken to identify the dominant member of thethe CD4−8− and to decrease the CD4+8+ thymocyte
subpopulations (79). insulin family expressed in the thymic microenvironment. By
immunocytochemistry with a panel of specific Abs directedA series of anterior pituitary hormone immunoreactivities
have been detected in different TEC subpopulations of the against distinct epitopes of the insulin family, ir-IGF-2 was
identified as the dominant member of the insulin familyhuman thymus. These TEC populations are separate from
OT/VP/neurophysin-containing epithelial cells. However, it expressed by TEC/TNC (83). A mAb against proinsulin (the
specific epitope of which is centred against the histidineis not yet clear whether these hormones are locally synthesized
or sequestered in TEC from peripheral blood (80), though residue at position 10 of the B chain) (84) revealed a slight
labelling, but outside thymic lobules, in the interstitial tissuethey have also been identified in cultured rat thymic
fragments (81). of the thymic capsule and in interlobular septae. Thymic
labelling was also negative with mAbs against the C-terminal
part of the insulin B chain. A few IGF-1 positive cells wereThymic expression of insulin-related genes
stained in thymic lobules but they were not epithelial; their
distribution and morphology were similar to those of macro-In 1965, on the basis that AKR female mice develop hypogly-
caemia and thymic hyperplasia associated with lymphoid phages. Of interest, murine macrophages were shown to
express IGF-1 Ea and Eb transcripts (85). Interferon cleukaemia, Pansky et al. reported the presence of an insulin-
like peptide within the thymus of AKR strain mice, as well inhibits macrophage IGF–1 at the transcriptional level (86),
whereas colony-stimulating factors induce IGF-1 mRNAas of bovine and porcine species (82). Mouse thymic extracts
induced a marked hypoglycaemia when injected into young (87). Ir-IGF-2 was not detected in the supernatant of human
TEC primary cultures and, with the use of confocal micro-female AKR mice. The biological action of thymic extracts
even exceeded that of similarly prepared pancreatic extracts. scopy, a large part of ir-IGF-2 was found to be associated
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with the outer surface of TEC plasma membranes. This was Jurkat T cells (100). Only IGF–2 (and to a lesser extent,
IGF–1) but not insulin could compete with [125I ]-IGF-2,not the case neither for IGF-1, nor for insulin. In the human
thymus, IGF-2, IGF-1 and (pro)insulin concentrations were, with an ED50 around 10 n. By affinity cross-linking, the
IGF binding site expressed by lymphocytes was found torespectively: 96.7±10.6 ng/g, 42.9±5.0 ng/g, and<0.1 ng/g
wet weight. IGF2 transcripts have been isolated from whole have a molecular weight (±260 kDa) similar to the type 2
IGF receptor described on other cells. Treatment of murinehuman thymic extracts, as well as from primary cultures of
human TEC. With RT-PCR and different specific primers, FTOC with a polyclonal Ab against type 2 IGF receptor
inhibited the early steps of T cell differentiation, with anthe expression of IGF2 in the human thymus was found to
be controlled by the same promoters as in other foetal and increase of CD4−8− (double negative) and a decrease of
CD4+8+ (double positive) thymocytes (101).adult extrahepatic tissues (88, 89). The effects of Igf2 over-
expression under the control of the MHC H-2Kb promoter
have been investigated by the generation of transgenic mice. Some principles and advantages of thymic T cell education to
The highest levels of transgene expression were found in neuroendocrine self-antigens
thymus and spleen. Only the thymus showed a significant
increase of weight in these transgenic mice, in agreement with A model has been proposed according which neuroendocrine-
related thymic polypeptides engage two distinct types ofthe high mRNA expression within this organ (90).
Going back to the initial observations made by Pansky interactions with pre-T cells depending on their involvement
as self-antigens of their family or as cryptocrine signalset al. there is now evidence that the thymic insulin-like
reticular factor corresponds to IGF-2. The IGF-2 structure (Table 2 (102)), The interaction of neuroendocrine self-
antigens with their corresponding TCR implies a binding ofclosely related to (pro)insulin explains a cross-reactivity with
the polyclonal Abs directed against insulin that were used in moderate affinity (10−6–10−8 M), but with a high selectivity.
Neuroendocrine self-antigens usually correspond to peptide1965. The hypoglycaemic properties of IGF-2 have been well
described (91) and might explain the biological activity of sequences of neuroendocrine precursors which have been
highly conserved during evolution. On the other hand,thymic extracts on glucose metabolism. Moreover, the syn-
drome of hypoglycaemia and lymphoid leukaemia associated cryptocrine signalling between thymic neuroendocrine-related
peptides and their cognate receptors expressed by pre-T cellswith thymic hyperplasia of some AKR female mice could
result from the overexpression of Igf2 in hyperplastic thymic implies a high-affinity binding(10−10–10−11 M ), but with a
low selectivity. Moreover, a hierarchy of dominance appearsepithelium, with a subsequent secretion of IGF-2 in the
bloodstream, and a profoundly disturbed thymic T cell in the organization of the polypeptide repertoire expressed in
the thymus (Table 1). This is significant since self-tolerancelymphopoiesis.
The hypothesis of a central T cell tolerance of the insulin primarily concerns self-determinants that are dominant on
self-molecules (103–105).family and, secondarily, of the peripheral insulin-secreting
pancreatic islet b cells was further supported by the observa- Some selective advantages appear from this model of
thymic neuroendocrine-related precursors of cryptocrine sig-tion that transcripts of proinsulin and of 67-kDa isoform of
glutamic acid decarboxylase (GAD) genes can be detected in nals and self-antigens in T cell positive and negative selection,
respectively. A first advantage is the absence of a tight allelicthe murine thymus with 30 cycles of RT-PCR (92). Thymic
insulin gene (INS) expression was highest in perinatal mice restriction in thymic T cell education to neuroendocrine famil-
ies. Such an allelic restriction of central T cell tolerance ofand persisted until 12 weeks of age. Two recent papers
confirmed these findings and reported that INS transcripts, neuroendocrine families was hardly conceivable and our data
seem to indicate that it is not the case in reality. Concerningas well as (pro)insulin protein can be detected at very low
levels (100–1000 fmol/g wet weight) in the human foetal the presentation of thymic OT for example, our data suggest
that, though MHC class I molecules are involved in thethymus (93, 94). The question of an illegitimate INS trancrip-
tion was ruled out by the RIA detection of ir-(pro)insulin process, it is the invariant neurophysin domain of the hybrid
membrane 55-kDa protein that may bind OT for presentationwithin thymic tissues. Preliminary in-situ hybridization
studies have shown INS transcripts within murine thymic to pre-T cells. Another selective advantage resides in the
potential presentation to pre-T cells of the structure character-dendritic cells, but presence of the protein could not be evi-
denced by immunocytochemistry (Homo-Delarche, personal istic of the neurohypophysial family. With regard to the
thymic presentation of NT, there is no physical constraintcommunication).
Type 1 and type 2 IGF receptors have been detected on for a non-covalent binding to MHC since this neuropeptide
is a linear peptide (in contrast to cyclic OT and IGF-2). Inrat thymocytes and murine thymoma cells (95), on human
phytohemagglutinin A (PHA)-activated T cells and on anti- addition, the C-terminal sequence of NT includes tyrosine,
isoleucine and leucine residues which can all be used in theCD3-activated human T lymphocytes (96, 97). Kooijman
et al. (98) have described a differential expression of type 1 anchorage to most of the MHC class I alleles. Given
these characteristics, it is logical to postulate that NT andIGF receptors in relation to the stage of activation and
differentiation of human T lymphocytes. Interestingly, in Igf2 NT-derived C-terminal fragments could behave as natural
ligands for a majority (if not all ) of MHC class I alleles.transgenic mice, the increased thymic cellularity is associated
with a stimulated generation of phenotypically normal T cells, This hypothesis is also in agrement with the high degree of
conservation of NT-related C-terminal region throughoutin particular CD4 T cells (99). In our hands, using radiobind-
ing assays, specific type 2 IGF binding sites were detected on evolution (106).
For IGFs, the role of binding and transport proteins isa murine immature T cell line (RL12−NP), as well as on
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Accessory signal in T cell development T cell education to neuroendocrine
and activation ( positive selection) families (negative selection of self-reactive T cells)
Pathophysiology Pathophysiology
Oversecretion in the bloodstream Failure (or breakdown) of immunological
(paraneoplastic syndrome) tolerance to neuroendocrine families
Involvement in the biology of T cell Autoimmune endocrine diseases
lymphomas Pharmacology
Pharmacology ‘Reprogramming’ of the immunological
Immunomodulation by neuropeptide tolerance to neuroendocrine families
agonists or antagonists ‘Tolerogenic’ vaccination for prevention
of autoimmune endocrine diseases
The interaction between neuroendocrine signals and receptors according to the cryptocrine model of cell signalling is involved in T cell positive
selection and development. Thymic neuroendocrine precursors are also the source of neuroendocrine self antigens which are presented by thymic
MHC class I molecules. This presentation could induce the negative selection or of self-reactive T cells oriented against neuroendocrine families.
ensured by IGF-binding proteins (IGFBPs). IGF-binding
proteins have co-evolved with IGFs, but are not part of IGF
precursors, and are encoded by distinct genes. These proteins
play a prominent role in regulating the bioavailability and
distribution of IGFs (107, 108). Interestingly, some IGFBPs
are in close relationship with cell plasma membranes (through
binding to integrins or the extracellular matrix), but their
relationship with MHC as well as their potential implication
in thymic IGF presentation to immature T cells deserve to
be further investigated.
The immunological recognition of neuroendocrine families
In parallel with the increasing complexity of cell-to-cell
signalling (from the primitive steps of autocrine, adhesion,
paracrine and cryptocrine signalling to the (neuro)endocrine
and complex neuronal networks in the central nervous
system), there exists a counterpart in the organization of the
F. 1. The immunological recognition of neuroendocrine families. Agenetic support responsible for chemical communication
neuroendocrine family X includes endocrine factors ( X1), as well asbetween cells. New members in neuroendocrine families were related tissue growth factors ( X2, Xn). Through its related thymicidentified that were not classical endocrine hormones but polypeptide, the central tolerance of a neuroendocrine family firstly
mainly served as local growth- and differentiation-promoting concerns the dominant and highly conserved sequences of the family
autocrine/paracrine factors. Genes coding for these growth (self-antigen X ). Because of the homology between the members of one
family, the central tolerance is extended to all members, including thefactors are predominantly expressed during foetal life, and
endocrine factors which are not or poorly expressed in the thymus.they play an important role in embryonic development and
Active immunization against the hormone X1 implies that some antigenicorganogenesis. So, the neuroendocrine system, with all of its sequences are processed to be presented by dedicated antigen-presenting
components, has evolved to organize the internal body (the cells (APC) at the periphery, including the self-antigen X which is highly
tolerated and against which specific immunoglobulins (Ig) will be hardly‘self ’) with an increasing complexity in the cell-to-cell signal-
raised after a long immunization procedure.ling pathways, the current highest level being observed in the
neural nets of the human central nervous system (109). On
the other side, the immune system has evolved to protect the some endocrine members of a family (i.e. VP or insulin) may
be detected at low levels within the thymic microenvironment,identity of self from aggression by infectious non-self.
When approaching the problem of the immunological the thymic tolerogenic function predominantly concerns their
homologous dominant thymic growth factors (i.e. OT orrecognition of neuroendocrine protein families (Fig. 1), two
levels should be distinguished. At the central level of the IGF-2, respectively). Through the central tolerance of the
dominant thymic factor however, the tolerogenic influencethymus, T cell recognition of neuroendocrine-derived self-
antigens primarily induces deletion of self-reactive T cell could extend to all members of the family.
At the peripheral level, active immunization againt aclones by apoptosis or developmental arrest. As discussed
before, T cell tolerance firstly concerns the dominant and hormone X corresponds to the experimental breakdown of
the immunological tolerance established for the family. Forhighly conserved sequence peptides of proteins. Thus, even if
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those who have tried to raise Abs against an endocrine and DP BB rats. A peak of ir-IGF-2 >10 ng/mL was
observed in the G75 profile of WF thymus extracts; a peakfactor or against its homologous related tissue growth
factors, it is a classic experience that the titre and the around 1.5 ng/mL was eluted from DR BB rat thymic
extracts, while IGF–2 concentrations were almost undetect-frequences of Abs against the endocrine factor are higher
than those of Abs against related growth factors. Capra able in DP BB rats (121). Together, these observations
strongly support the hypothesis that a defective thymic cen-noted in 1975 that, early in immunization with neurophysins,
the antisera did not cross-react with neurophysins of other sorship or T cell self-education is actively involved in the
pathophysiology of autoinimune type 1 diabetes.species (110). Later, in a prolonged immunization procedure,
extensively cross-reacting antisera were obtained. It is
plausible that early antisera are directed against ‘cryptic’, Neuroendocrine self-antigens versus autoantigens: toward the
and specific determinants of the molecule with low levels of design of tolerogenic vaccines for the prevention of
tolerance; while later, when the tolerance of the whole autoimmune diseases?
family has been broken, the antisera are orientated against
dominant, and highly conserved epitopes with high levels of Three types of factors are usually thought to be implicated
in the pathogeny of autoimmune diseases:tolerance.
1. The effector immune components are CD4 and CD8
A role played by a trouble of thymic T cell education in autoreactive T cells which are specifically orientated against
autoimmunity? a given target cell or molecule. These autoreactive T cells
result from a spontaneous breakdown of T cell tolerance,The development of an autoimmune disease affecting the
either at the central thymic and/or the peripheral level.
neuroendocrine system may be viewed as a failure to develop 2. A series of extra- and intra-MHC genes are related to
or maintain tolerance to cellular or molecular components
different autoimmune diseases. Some of these genes couldwhich are constitutively expressed by neuroendocrine
intervene in the presentation of target autoantigens to auto-
cells (i.e. autoantigens such as insulin or GAD). Though reactive T lymphocytes, but others certainly not.
the relationship between lymphoepithelial structures and
3. Finally, an environmental factor is involved and couldautoimmunity has been suspected in 1962 by Burnet and
be implicated in establishing a link between the target auto-
Mackay (111), the question of a defective thymic T cell antigens and autoreactive T cells. A molecular mimicry
negative selection or self-education in the pathophysiology of
between target autoantigens and micro-organisms may inter-autoimmune diseases has not been intensively investigated.
vene at this level (122). The involvement of microbial super-
Nevertheless, it has been shown that neonatal thymectomy antigens has also been proposed to activate peripheral
prevents the emergence of diabetes in an animal model of
autoreactive T cells (123). A preventive strategy of auto-autoimmune type 1 diabetes, the Bio-Breeding (BB) rat
immune diseases can hardly be designed on the basis of the
(112). In clinical practice also, thymectomy usually induces genetic components of autoimmune disease or the hazardous
an improvement in patients suffering from autoimmune
environmental factors. Manipulation of autoreactive T cellsmyasthenia gravis, especially when a thymoma (hyperplasia
seems to be a more promising way by which an efficient
of thymic epithelium) is associated (113). In both cases, the prevention of autoimmunity can be envisioned.
benefit of thymectomy may result from the removal of the
defective thymic censorship which is responsible for a continu- In the neurohypophysial family, evidence has been pre-
sented that OT seems to be the neurohypophysial self-antigen.ous release and enrichment of the peripheral T cell pool with
intolerant and self-reactive lymphocytes. The development of A strong immunological tolerance protects the OT lineage,
more than the VP one, from autoimmune aggression. Indeed,diabetes is prevented by the transplantation of thymus from
diabetes-resistant (DR) to diabetes-prone (DP) BB rats (114). some cases of idiopathic diabetes insipidus result from an
autoimmune hypothalamitis orientated toward VP-producingThe transplantation of the thymus from non-obese diabetic
(NOD) mice to DR mouse strains was also shown to induce neurones (124, 125). Given the implication of the OT lineage
in the reproductive process, a stronger tolerance of thisdiabetes in the recipients (115). While bone marrow trans-
plantation is rather ineffective in preventing autoimmune lineage is important for the preservation of the species. Thus,
in the neurohypophysial family, while OT behaves as the self-diseases of MRL/+ mice, thymus transplantation is a crucial
factor for their prevention (116). A defective process of antigen, VP is suspected to be one target autoantigen of the
autoimmune process. As discussed previously, this conclusionthymic T cell negative selection has been suggested on the
basis that the thymus of DR BB rats contains thymocytes is also supported by the frequences and the titres of Abs
induced by active immunization against neurohypophysialpredisposed to autoreactivity (117). Another argument is the
observation that grafts of pure thymic epithelium from NOD peptides (VP>>OT). An infiltration of the hypothalamo-
neurohypophysial tract by inflammatory mononuclear cellsmouse embryos to newborn C57BL/6 athymic mice induced
CD4 and CD8 T cell mediated insulitis and sialitis (118). At has been observed repeatedly, both after active immunization
against VP (126), and in spontaneous diabetes insipidusthe histological level, a defect in thymic function could be
linked to a disorganization of the microenvironment, such as (120). These observations suggest that hypothalamic magno-
cellular neurones express, on their surface, antigenic markersthe giant perivascular spaces observed in the NOD mouse
thymus (119), and the epithelial defects of BB rat thymus specific of their neurosecretory activity.
There is now significant evidence that insulin is one import-(120). Recently, we examined the elution profiles of ir-IGFs
in the thymus from Wistar Furth ( WF) normal rats, DR ant autoantigen which is dealt with by various autoreactive
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stimulate murine thymocyte proliferation. Int Arch Allergy Appl locus for type 1 diabetes. Nature Genet 1997; 15: 293–297.
95 Verland S, Gammeltoft S. Functional receptors for insulin-like growthImmunol 1989; 90: 91–96.
75 Geppetti P, Theodorsson-Norheim E, Ballerini G, Alessandri M, Maggi factors I and II in rat thymocytes and mouse thymoma cells. Mol Cell
Endocrinol 1989; 67: 207–216.CA, Santicioli P, Amenta F, Fanciullacci M. Capsaicin-sensitive tachyki-
nin-like immunoreactivity in the thymus of rats and guinea pigs. 96 Kozak RW, Hassell JF, Greenstein LA, Rechler MM, Waldmann TA,
Nissley SP. Type 1 and 2 insulin-like growth factor receptors on humanJ Neuroimmunol 1988; 19: 3–9.
76 Shigematsu K, Saavedra JM, Kurihara M. Specific substance P binding phytohemagglutinin-activated lymphocytes. Cell Immunol 1987; 109:
318–33 1.sites in rat thymus and spleen: in vitro autoradiographic study. Regul
Pept 1986; 16: 147–56. 97 Johnson EW, Jones LA, Kozak RW. Expression and function of
insulin-like growth factor receptors on anti-CD3-activated human T77 Vollmar AM, Schulz R. Atrial natriuretic peptide is synthesized in the
human thymus. Endocrinology 1990; 126: 2227–2281. lymphocytes. J Immunol 1992; 148: 63–71.
98 Kooijman R, Scholtens LE, Rijkers; GT, Zegers BJM. Differential78 Vollmar AM, Wolf R, Schulz R. Co-expression of the natriuretic
peptides (ANP, BNP, CNP) and their receptors in normal and acutely expression of type 1 insulin-like growth factor receptors in different
stages of human T cells. Eur J Immunol 1995; 25: 931–5.involuted rat thymus. J Neuroimmunol 1995; 57: 117–127.
79 Vollmar AM. Influence of atrial natriuretic peptide on thymocyte 99 Kooijman R, van Buul-Offers SC, Scholtens LE, Schuurman HJ, Van
den Brande JL, Zegers BJM. T cell development in insulin-like growthdevelopment in fetal thymic organ culture. J Neuroimmunol 1997;
78: 90–96. factor-II transgenic mice. J Immunol 1995; 154: 5736–45.
100 Goxe B, Martens H, Vandersmissen E, Achour I, Kecha O, Geenen V.80 Batanero E, De Leeuw FE, Jansen GH, Van Wicken DF, Huber J,
Schuurman HJ. The neural and neuroendocrine component of the Interactions entre les cellules T et la famille insulinique: étude du
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